Ultrasound validation of predictive model for central cervical lymph node metastasis in papillary thyroid cancer on BRAF

被引:9
作者
Chen, Jie [1 ,2 ,3 ,4 ]
Li, Xiao-Long [1 ,2 ,3 ]
Zhang, Yi-Feng [1 ,2 ,3 ]
Wang, Dan [1 ,2 ,3 ]
Wang, Qiao [1 ,2 ,3 ]
Zhao, Chong-Ke [1 ,2 ,3 ]
Li, Ming-Xu [1 ,2 ,3 ]
Wei, Qing [5 ]
Ji, Guo [5 ]
Xu, Hui-Xiong [1 ,2 ,3 ]
机构
[1] Tongji Univ, Shanghai Peoples Hosp 10, Ultrasound Res & Educ Inst, Dept Med Ultrasound,Sch Med, Shanghai 200072, Peoples R China
[2] Tongji Univ, Thyroid Inst, Sch Med, Shanghai 200072, Peoples R China
[3] Shanghai Ctr Thyroid Dis, Shanghai 200072, Peoples R China
[4] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Dept Med Ultrasound, Sch Med, Shanghai 200030, Peoples R China
[5] Tongji Univ, Shanghai Peoples Hosp 10, Dept Pathol, Sch Med, Shanghai 200072, Peoples R China
基金
中国国家自然科学基金;
关键词
BRAF(V600E) mutation; central cervical lymph node metastasis; papillary thyroid carcinoma; predictive model; ultrasound; POWER DOPPLER; MICROCARCINOMA; MUTATION; CARCINOMA; NODULES; RISK; OSTEOPONTIN; SYSTEM; ASSOCIATION; DIAGNOSIS;
D O I
10.2217/fon-2020-0069
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aim: To compare the value of predictive power of the models for central cervical lymph node metastasis (CLNM) in papillary thyroid carcinomas (PTCs). Patients & methods: 220 PTCs were prospectively enrolled into the study with pathological examination. We established a new risk model with univariate and multivariate analyses and receiver-operating characteristic curves were plotted. Z-test was performed to compare the area under two curves and validated the predictive model for central CLNM in PTCs. The comparison of previous and new predictive model was analyzed. Results: Microcalcification, capsule contact or involvement, internal flow and BRAF(V600E) mutation were four independent risk factors for PTCs with central CLNMs. The area under the curves for the new and the previous model were 0.948 and 0.934 (p = 0.572), respectively. Conclusion: Two predictive models showed strong consistency in predicting central CLNM in PTCs. The predictive model may be helpful in selecting appropriate treatment method in PTCs.
引用
收藏
页码:1607 / 1618
页数:12
相关论文
共 39 条
[1]   Thyroid nodules: Evaluation with power Doppler and duplex Doppler ultrasound [J].
Chammas, MC ;
Gerhard, R ;
De Oliveira, IRS ;
Widman, A ;
De Barros, N ;
Durazzo, M ;
Ferraz, A ;
Cerri, GG .
OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2005, 132 (06) :874-882
[2]   CONVENTIONAL ULTRASOUND, IMMUNOHISTOCHEMICAL FACTORS AND BRAFV600E MUTATION IN PREDICTING CENTRAL CERVICAL LYMPH NODE METASTASIS OF PAPILLARY THYROID CARCINOMA [J].
Chen, Jie ;
Li, Xiao-Long ;
Zhao, Chong-Ke ;
Wang, Dan ;
Wang, Qiao ;
Li, Ming-Xu ;
Wei, Qing ;
Ji, Guo ;
Xu, Hui-Xiong .
ULTRASOUND IN MEDICINE AND BIOLOGY, 2018, 44 (11) :2296-2306
[3]   Long-term oncologic outcomes of papillary thyroid microcarcinoma according to the presence of clinically apparent lymph node metastasis: a large retrospective analysis of 5,348 patients [J].
Choi, Jung Bum ;
Lee, Woo Kyung ;
Lee, Seul Gi ;
Ryu, Haengrang ;
Lee, Cho Rok ;
Kang, Sang Wook ;
Jeong, Jong Ju ;
Nam, Kee-Hyun ;
Lee, Eun Jig ;
Chung, Woong Youn ;
Jo, Young Suk ;
Lee, Jandee .
CANCER MANAGEMENT AND RESEARCH, 2018, 10 :2883-2891
[4]   Papillary microcarcinoma of the thyroid - Prognostic significance of lymph node metastasis and multifocality [J].
Chow, SM ;
Law, SCK ;
Chan, JKC ;
Au, SK ;
Yau, S ;
Lau, WH .
CANCER, 2003, 98 (01) :31-40
[5]  
Du J, 2015, ULTRASOUND MED BIOL
[6]   Predictive factors for central lymph node and lateral cervical lymph node metastases in papillary thyroid carcinoma [J].
Feng, J. -W. ;
Yang, X. -H. ;
Wu, B. -Q. ;
Sun, D. -L. ;
Jiang, Y. ;
Qu, Z. .
CLINICAL & TRANSLATIONAL ONCOLOGY, 2019, 21 (11) :1482-1491
[7]   Value of the cervical compartments in the surgical treatment of papillary thyroid carcinoma [J].
Goropoulos, A ;
Karamoshos, K ;
Christodoulou, A ;
Ntitsias, T ;
Paulou, K ;
Samaras, A ;
Xirou, P ;
Efstratiou, I .
WORLD JOURNAL OF SURGERY, 2004, 28 (12) :1275-1281
[8]   Differentiated Thyroid Cancer: Focus on Emerging Treatments for Radioactive Iodine-Refractory Patients [J].
Gruber, Joshua J. ;
Colevas, A. Dimitrios .
ONCOLOGIST, 2015, 20 (02) :113-126
[9]   Osteopontin is overexpressed in human papillary thyroid carcinomas and enhances thyroid carcinoma cell invasiveness [J].
Guarino, V ;
Faviana, P ;
Salvatore, G ;
Castellone, MD ;
Cirafici, AM ;
De Falco, V ;
Celetti, A ;
Giannini, R ;
Basolo, F ;
Melillo, RM ;
Santoro, M .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (09) :5270-5278
[10]   2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer [J].
Haugen, Bryan R. ;
Alexander, Erik K. ;
Bible, Keith C. ;
Doherty, Gerard M. ;
Mandel, Susan J. ;
Nikiforov, Yuri E. ;
Pacini, Furio ;
Randolph, Gregory W. ;
Sawka, Anna M. ;
Schlumberger, Martin ;
Schuff, Kathryn G. ;
Sherman, Steven I. ;
Sosa, Julie Ann ;
Steward, David L. ;
Tuttle, R. Michael ;
Wartofsky, Leonard .
THYROID, 2016, 26 (01) :1-133